Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María José Aladrén"'
Autor:
María O. López-Oliva, Isabel Pérez-Flores, María Molina, María José Aladrén, Hernando Trujillo, Dolores Redondo-Pachón, Verónica López, Carme Facundo, Florentino Villanego, Marisa Rodríguez, Maria Carmen Ruiz, Paula Antón, Alba Rivas-Oural, Sheila Cabello, José Portolés, Lourdes de la Vara, Guadalupe Tabernero, Rosalía Valero, Cristina Galeano, Esperanza Moral, Ana Ventura, Armando Coca, Miguel Ángel Muñoz, Román Hernández-Gallego, Amir Shabaka, Gabriel Ledesma, Hanane Bouarich, María Ángeles Rodríguez, Lourdes Pérez Tamajón, Leónidas Cruzado, José Emilio Sánchez, Carlos Jiménez
Publikováno v:
Nefrología (English Edition), Vol 43, Iss 4, Pp 442-451 (2023)
Introduction: SARS CoV2 infection has had a major impact on renal transplant patients with a high mortality in the first months of the pandemic. Intentional reduction of immunosuppressive therapy has been postulated as one of the cornerstone in the m
Externí odkaz:
https://doaj.org/article/cf673a54b62044a5bea2924837531c6e
Autor:
Maria Luisa Martin, Cristina Canal, Carlos Arias-Cabrales, Antonio Franco, Francesc Moreso, Isabel María Saura, Luis Sanchez-Cámara, Sofía Zárraga, Sheila Cabello Pelegrin, Julio Pascual, Emilio Sánchez-Álvarez, Inmaculada Lorenzo, Anna Buxeda, Raquel Santana-Estupiñán, Edoardo Melilli, María José Aladrén, Esperanza Moral Berrio, Judit Cacho, Marta Crespo, Orlando Siverio, Auxiliadora Mazuecos, José Portolés, Verónica López, Elena González-García, Paloma L Martin-Moreno, Iñigo Moina, María José Pérez-Sáez, Cristina Galeano, María del Carmen Ruiz-Fuentes
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Kidney International Reports
Repositorio Abierto de la UdL
Universitad de Lleida
Universidad de Barcelona
Scientia
Kidney International Reports
Repositorio Abierto de la UdL
Universitad de Lleida
Introduction:Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time torecovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acutekidney injury have been reported. Scant data are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cdc51c2c636a142b6db03dcb01ada0c
http://hdl.handle.net/10230/52789
http://hdl.handle.net/10230/52789
Autor:
Ricardo Lauzurica, Jesus Calviño, Manel Perelló, Ana I. Sánchez Fructuoso, Dolores Redondo, María José Aladrén, Isabel Beneyto, Jose Manuel Gonzalez Posada, Secundino Cigarrán, Gonzalo Gomez, Amado Andrés, Ana Ramos, Nuria Serra, Fritz Diekmann, Juan Carlos Ruiz, Antonio Franco, Ana Manonelles, Andres Lopez Muñiz
Publikováno v:
Clinical Transplantation. 34
Tacrolimus is the cornerstone of immunosuppressive therapy after kidney transplantation. Its narrow therapeutic window mandates serum level strict monitoring and dose adjustments to ensure the optimal risk-benefit balance. This observational retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cbb1ae6c5da503765212293151d6824
https://doi.org/10.1111/ctr.13767
https://doi.org/10.1111/ctr.13767
Autor:
Ana, Sánchez Fructuoso, Juan Carlos, Ruiz, Antonio, Franco, Fritz, Diekmann, Dolores, Redondo, Jesús, Calviño, Nuria, Serra, María José, Aladrén, Secundino, Cigarrán, Ana, Manonelles, Ana, Ramos, Gonzalo, Gómez, José Manuel, González Posada, Amado, Andrés, Isabel, Beneyto, Andrés López, Muñiz, Manel, Perelló, Ricardo, Lauzurica
Publikováno v:
Clinical Transplantation
Tacrolimus is the cornerstone of immunosuppressive therapy after kidney transplantation. Its narrow therapeutic window mandates serum level strict monitoring and dose adjustments to ensure the optimal risk‐benefit balance. This observational retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39a80567db1ea1266bcc047d276d1002
https://pubmed.ncbi.nlm.nih.gov/31815310
https://pubmed.ncbi.nlm.nih.gov/31815310
Autor:
Ricardo Gómez, Luis Miguel Lou, María José Aladrén, Pedro José Vives, Rosario Moreno, Antonio Gascón, R. Virto, Jose Antonio Gutierrez-Colón, B. Moragrega, Jesus Perez Perez, Raquel Pernaute, Francisco Javier García-Labat, Jesús Castilla, Rafael Álvarez, Elena Castillón
Publikováno v:
Diálisis y Trasplante. 29:14-20
Resumen Introduccion La optima utilizacion de la eritropoyetina humana recombinante (rHuEPO) tiene importancia en la efectividad del tratamiento de la anemia en los pacientes en hemodialisis (HD) y en la reduccion del coste economico. Para alcanzar e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc57e61400ebae1bd7170a9711fa61af
https://doi.org/10.1016/s1886-2845(08)70615-5
https://doi.org/10.1016/s1886-2845(08)70615-5